Ana Figueiras

3.7k total citations
99 papers, 2.8k citations indexed

About

Ana Figueiras is a scholar working on Molecular Biology, Pharmaceutical Science and Biomaterials. According to data from OpenAlex, Ana Figueiras has authored 99 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Molecular Biology, 29 papers in Pharmaceutical Science and 20 papers in Biomaterials. Recurrent topics in Ana Figueiras's work include RNA Interference and Gene Delivery (32 papers), Drug Solubulity and Delivery Systems (20 papers) and Advanced biosensing and bioanalysis techniques (18 papers). Ana Figueiras is often cited by papers focused on RNA Interference and Gene Delivery (32 papers), Drug Solubulity and Delivery Systems (20 papers) and Advanced biosensing and bioanalysis techniques (18 papers). Ana Figueiras collaborates with scholars based in Portugal, Spain and Brazil. Ana Figueiras's co-authors include Francisco Veiga, Ivana Jarak, Carmen Alvarez‐Lorenzo, Ana Cláudia Paiva‐Santos, Rui A. Carvalho, Mariana Magalhães, Fani Sousa, Patrícia Pereira, Cátia Domingues and Ángel Concheiro and has published in prestigious journals such as ACS Nano, Scientific Reports and Carbon.

In The Last Decade

Ana Figueiras

96 papers receiving 2.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ana Figueiras Portugal 31 917 647 636 433 357 99 2.8k
Muhammad Sohail Pakistan 35 1.2k 1.3× 813 1.3× 906 1.4× 626 1.4× 457 1.3× 136 3.6k
Vanna Sanna Italy 35 872 1.0× 832 1.3× 722 1.1× 874 2.0× 572 1.6× 69 3.8k
Mohammad Javed Ansari Saudi Arabia 34 806 0.9× 822 1.3× 720 1.1× 792 1.8× 557 1.6× 135 4.0k
Hyo‐Kyung Han South Korea 36 1.1k 1.2× 702 1.1× 944 1.5× 550 1.3× 419 1.2× 99 3.5k
Ali Mohammad Tamaddon Iran 30 948 1.0× 812 1.3× 389 0.6× 636 1.5× 509 1.4× 153 2.9k
Kristiina Järvinen Finland 39 884 1.0× 664 1.0× 1.4k 2.2× 648 1.5× 636 1.8× 113 4.0k
Shahzeb Khan Pakistan 34 771 0.8× 1.2k 1.8× 796 1.3× 761 1.8× 421 1.2× 106 3.9k
Ketan Patel United States 37 2.1k 2.3× 489 0.8× 720 1.1× 566 1.3× 398 1.1× 149 5.6k
Shahla Ataei Iran 11 934 1.0× 962 1.5× 914 1.4× 705 1.6× 644 1.8× 21 3.8k
Zhenghong Wu China 27 729 0.8× 651 1.0× 485 0.8× 516 1.2× 199 0.6× 81 2.2k

Countries citing papers authored by Ana Figueiras

Since Specialization
Citations

This map shows the geographic impact of Ana Figueiras's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ana Figueiras with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ana Figueiras more than expected).

Fields of papers citing papers by Ana Figueiras

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ana Figueiras. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ana Figueiras. The network helps show where Ana Figueiras may publish in the future.

Co-authorship network of co-authors of Ana Figueiras

This figure shows the co-authorship network connecting the top 25 collaborators of Ana Figueiras. A scholar is included among the top collaborators of Ana Figueiras based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ana Figueiras. Ana Figueiras is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Domingues, Cátia, Ivana Jarak, Jorge F. J. Coelho, et al.. (2025). Optimizing Pluronic–PEI Nanocarriers for RNAi Delivery in Oral Cancer: From Polymer Synthesis to Functional Screening. Biomacromolecules. 26(11). 7484–7511.
2.
Domingues, Cátia, Ivana Jarak, Ana Miguel Matos, et al.. (2025). Unraveling rosmarinic acid anticancer mechanisms in oral cancer malignant transformation. European Journal of Pharmacology. 997. 177466–177466. 2 indexed citations
3.
Lohani, Alka, et al.. (2025). Tailored polymeric hydrogels for regenerative medicine and drug delivery: From material design to clinical applications. International Journal of Pharmaceutics. 681. 125818–125818. 3 indexed citations
4.
Figueiras, Ana, et al.. (2024). Regulation and Safety of Cosmetics: Pre- and Post-Market Considerations for Adverse Events and Environmental Impacts. Cosmetics. 11(6). 184–184. 4 indexed citations
5.
Jarak, Ivana, et al.. (2024). Polymersomes as the Next Attractive Generation of Drug Delivery Systems: Definition, Synthesis and Applications. Materials. 17(2). 319–319. 38 indexed citations
6.
Domingues, Cátia, et al.. (2023). The Debate between the Human Microbiota and Immune System in Treating Aerodigestive and Digestive Tract Cancers: A Review. Vaccines. 11(3). 492–492. 5 indexed citations
8.
Batista, Maria Teresa, et al.. (2023). Acanthus mollis Formulations for Transdermal Delivery: From Hydrogels to Emulsions. Gels. 10(1). 36–36. 3 indexed citations
9.
Figueiras, Ana, Cátia Domingues, Ivana Jarak, et al.. (2022). New Advances in Biomedical Application of Polymeric Micelles. Pharmaceutics. 14(8). 1700–1700. 62 indexed citations
10.
Domingues, Cátia, Ana Cláudia Paiva‐Santos, Carmen Alvarez‐Lorenzo, et al.. (2022). Where Is Nano Today and Where Is It Headed? A Review of Nanomedicine and the Dilemma of Nanotoxicology. ACS Nano. 16(7). 9994–10041. 142 indexed citations
11.
Domingues, Cátia, et al.. (2021). Osteosarcoma from the unknown to the use of exosomes as a versatile and dynamic therapeutic approach. European Journal of Pharmaceutics and Biopharmaceutics. 170. 91–111. 11 indexed citations
12.
Domingues, Cátia, Ivana Jarak, Carla Varela, et al.. (2020). Synthesis and Characterization of a Novel Nanomicellar System Pluronic-PEI Suitable for Gene and Drug Co-Delivery in Cancer Therapy. MDPI (MDPI AG). 36–36. 1 indexed citations
13.
Pereira‐Silva, Miguel, Ivana Jarak, Carmen Alvarez‐Lorenzo, et al.. (2020). Micelleplexes as nucleic acid delivery systems for cancer-targeted therapies. Journal of Controlled Release. 323. 442–462. 48 indexed citations
14.
Domingues, Cátia, Carmen Alvarez‐Lorenzo, Ángel Concheiro, Francisco Veiga, & Ana Figueiras. (2019). Nanotheranostic Pluronic-Like Polymeric Micelles: Shedding Light into the Dark Shadows of Tumors. Molecular Pharmaceutics. 16(12). 4757–4774. 20 indexed citations
15.
Magalhães, Mariana, Carmen Alvarez‐Lorenzo, Ángel Concheiro, et al.. (2018). RNAi-based therapeutics for lung cancer: biomarkers, microRNAs, and nanocarriers. Expert Opinion on Drug Delivery. 15(10). 965–982. 13 indexed citations
16.
Simões, Ana, Francisco Veiga, Ana Figueiras, & Carla Vitorino. (2018). A practical framework for implementing Quality by Design to the development of topical drug products: Nanosystem-based dosage forms. International Journal of Pharmaceutics. 548(1). 385–399. 31 indexed citations
17.
Figueiras, Ana. (2016). APLICAÇÕES TERAPÊUTICAS DE SISTEMAS MICELARES POLIMÉRICOS. 7(2). 48. 1 indexed citations
18.
Figueiras, Ana. (2016). DESENVOLVIMENTO DE SISTEMAS MUCOADESIVOS PARA A ADMINISTRAÇÃO CONTROLADA DE FÁRMACOS. 7(2). 63. 1 indexed citations
19.
Figueiras, Ana, et al.. (2014). Nanotecnologia na saúde: aplicações e perspectivas. 5(2). 14. 3 indexed citations
20.
Bermejo, J., Rosa Menéndez, Ana Figueiras, & Marcos Granda. (1995). The role of low-molecular-weight components in the pyrolysis of pitches. Fuel. 74(12). 1792–1799. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026